Trinbelimab Biosimilar - Research Grade

Human

RHDï؟½

5mg/ml

IgG1 - lambda3

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q02161

Blue ice

The Rhesus D (RhD) antigen is a key red-cell surface protein and a driver of alloimmunization in hemolytic-disease research. Offered here is a research-grade, unconjugated analog of trinbelimab, a recombinant anti-RhD monoclonal antibody for research use only. It is manufactured to in vivo standards with low endotoxin and produced in scalable milligram to gram quantities for high-throughput laboratories. The antibody supports erythrocyte-binding functional assays, in vitro alloantigen screens, and in vivo models examining antibody clearance and effector function. Dependable lot-to-lot consistency underpins reliable use across large and repeated experiments. Its reproducible formulation and scalable volumes support standardized results in bulk research.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks